Pharmaceutical Exports of OSD and External Preparation Plant

GMP Certified Pharmaceutical Company Fully Geared for Exports


1. Introduction

Cream Ointment Manufacturer in Vapi, Gujarat
Cream Ointment Manufacturer in Vapi, Gujarat

Taj Pharma is a GMP-certified pharmaceutical company with a focus on exporting Oral Solid Dosage (OSD) forms and external preparations is strategically positioned to meet global healthcare demands. These companies comply with international regulatory requirements, ensuring product quality, safety, and efficacy.


2. What Are OSDs and External Preparations?

Oral Solid Dosage Forms (OSDs):

These are the most common forms of pharmaceutical formulations, which include:

External Preparations:

Topical formulations applied to the skin or mucous membranes, including:


3. GMP Certification: A Key Export Enabler

GMP (Good Manufacturing Practice) certification ensures:

  • Compliance with WHO, PIC/S, or national drug regulatory standards.
  • Controlled manufacturing environments.
  • Proper documentation and traceability.
  • Quality assurance at every stage.

A GMP-certified facility is a prerequisite for pharmaceutical exports to regulated markets.


4. Plant Infrastructure & Capabilities

Key Plant Features:

  • Dedicated manufacturing zones for OSD and External Preparations.
  • HVAC-controlled clean rooms with ISO class compliance.
  • Automated processing units for blending, granulation, compression, and coating (for OSD).
  • Automated tube-filling, bottle-filling, and sealing machines for topicals.
  • Integrated QA/QC laboratories with HPLC, GC, UV-Vis, and dissolution systems.
  • Effluent treatment and waste management as per global environmental norms.
  • Separate quarantine and dispatch areas for export logistics.

Production Capacity Example:

Dosage FormCapacity (Monthly)
Tablets100 million units
Capsules50 million units
Creams/Ointments2 million tubes
Lotions/Solutions1 million bottles

5. Export Readiness & Regulatory Approvals

Certifications & Approvals:

  • WHO-GMP
  • PIC/S-compliant
  • Country-specific registrations (e.g., FDA Ghana, NDA Uganda, MOH Philippines, PPB Kenya)
  • Accredited dossiers: CTD/ACTD formats for ASEAN, GCC, Africa, and CIS nations

Regulatory Documentation:

  • DMFs (Drug Master Files)
  • COPPs (Certificates of Pharmaceutical Product)
  • Product Registration Dossiers
  • Stability Studies (Zone II & IV B)

International Markets Exported To:

  • Africa (Nigeria, Kenya, Ghana, South Africa)
  • CIS & Russia
  • Southeast Asia (Vietnam, Myanmar, Philippines)
  • Middle East (UAE, Yemen, Iraq)
  • Latin America (Peru, Bolivia, Guatemala)
  • Europe (under semi-regulated MOUs or via partners)

6. Product Portfolio for Export

Popular Export OSDs:

  • Paracetamol, Diclofenac, Metformin, Amoxicillin
  • Fixed-dose combinations (FDCs)
  • Anti-infectives, antimalarials, antihypertensives, and vitamins

Popular Export External Preparations:

  • Diclofenac Gel, Mupirocin Ointment, Ketoconazole Cream
  • Clotrimazole Cream, Hydrocortisone Cream, Antiseptic Lotions

7. Private Labeling & Contract Manufacturing for Export

Services Offered:

  • Private Label / Own Brand manufacturing
  • Customized packaging as per import country norms
  • Multilingual pack inserts and cartons
  • Regulatory support for registration dossiers
  • Contractual agreements for market exclusivity

8. Logistics & Supply Chain Strength

  • Integrated cold chain and ambient shipping capability
  • Strategic tie-ups with global logistics providers (DHL, Aramex, FedEx)
  • Sea & air freight flexibility
  • Batch traceability with serialization (Track & Trace)

9. Competitive Advantages

  • In-house R&D and formulation development
  • Speed-to-market for new registrations
  • Pricing competitiveness for tender-based markets
  • Flexible MOQs for startups or new market entrants
  • Ethical marketing support (where permissible)

Competitive Advantages in Pharmaceutical Exports (OSD & External Preparations)

GMP Certified Plant | Fully Geared for Global Markets


1. In-House R&D and Formulation Development

✅ Strategic Importance:

  • In-house Research and Development (R&D) is the cornerstone of pharmaceutical innovation.
  • It allows the company to develop, optimize, and scale formulations quickly for a wide array of international markets.

✅ Capabilities:

  • Pre-formulation studies to assess drug-excipient compatibility.
  • Development of bioequivalent generic formulations in line with pharmacopeial standards (IP, BP, USP, Ph. Eur).
  • Stability studies under ICH guidelines for multiple climatic zones (Zone II, IVa, IVb).
  • Analytical method validation for assay, dissolution, and impurity profiling.
  • Advanced formulation technologies: Sustained-release, dispersible, chewable, effervescent, and multilayer tablets.

✅ Export Advantage:

  • Tailor-made formulations to meet country-specific preferences or regulatory standards.
  • Quick adaptation to patent expiries and market exclusivity opportunities in various countries.

2. Speed-to-Market for New Registrations

✅ Strategic Importance:

  • A fast and agile regulatory and documentation team allows companies to launch products in new markets rapidly.
  • Critical in tender-based markets, where turnaround time determines success.

✅ Capabilities:

  • Preparation of CTD/ACTD dossiers with high-quality technical data and administrative modules.
  • Experienced in electronic Common Technical Document (eCTD) submission formats.
  • Capability to support Regulatory Queries (RQs) in real-time with prompt documentation.
  • Maintenance of ready-to-submit dossiers for high-demand generics.

✅ Export Advantage:

  • Enables faster market entry during tender cycles, government procurement rounds, or health emergencies.
  • Reduces time lost in regulatory back-and-forth, giving a first-mover advantage.

3. Pricing Competitiveness for Tender-Based Markets

✅ Strategic Importance:

  • Many developing and emerging countries procure medicines through government tenders, where pricing and quality are paramount.

✅ Capabilities:

  • Lean manufacturing systems to reduce overheads and maximize production efficiency.
  • Strategic sourcing of pharmaceutical-grade APIs and excipients from audited global suppliers.
  • In-house QC/QA reduces reliance on third-party testing, cutting costs further.
  • Access to economies of scale through high batch volumes and optimized production scheduling.

✅ Export Advantage:

  • Ability to offer competitive landed cost per pack while maintaining quality standards.
  • Enhanced bid-win rate for public health tenders (UNICEF, WHO-GDF, country-specific procurements).

4. Flexible Minimum Order Quantities (MOQs) for Startups and New Market Entrants

✅ Strategic Importance:

  • Not all partners are large-scale distributors. Startups or new players require low-volume, high-quality support to build initial traction.

✅ Capabilities:

  • Modular production lines that support low and mid-size batch manufacturing.
  • Personalized packaging with small-run customization (multilingual labeling, country-specific artwork).
  • Capability to split batches across multiple SKUs or brands.
  • Inventory risk sharing models in strategic partnerships.

✅ Export Advantage:

  • Lowers entry barriers for new distributors and startups in emerging markets.
  • Builds long-term loyalty by nurturing businesses from inception.
  • Suits pilot market launches, sample distributions, and test marketing campaigns.

5. Ethical Marketing Support (Where Permissible)

✅ Strategic Importance:

  • In markets where ethical marketing is legally permitted, pharmaceutical companies can build direct relationships with healthcare professionals to drive product adoption.

✅ Capabilities:

  • Provision of scientific promotional materials: Product monographs, brochures, and MOA (Mechanism of Action) visuals.
  • Medical representative training modules, brand launch kits, and physician sampling programs.
  • Participation in CME programs, health camps, and doctor-patient education initiatives.
  • Digital marketing support for DTC channels in countries where allowed.

✅ Export Advantage:

  • Helps build brand visibility and medical trust in new markets.
  • Enhances prescription generation for branded generics or specialty products.
  • Supports market penetration with targeted scientific communication.
  • Competitive Edge
AdvantageBenefit to Export Market
In-house R&DFaster, customized formulation availability
Speed-to-MarketShorter regulatory timelines, faster product launches
Competitive PricingIdeal for large-scale tenders and public procurement
Flexible MOQsPartner-friendly approach for new or small-scale markets
Ethical Marketing SupportScientific brand promotion and deeper market penetration

A GMP-certified pharmaceutical company with advanced OSD and external preparation manufacturing capabilities, geared for exports, plays a pivotal role in global healthcare delivery. Its strong regulatory foundation, robust infrastructure, diversified product portfolio, and export expertise allow it to efficiently serve both regulated and semi-regulated markets worldwide.